Results 9,001-9,020 of 24,567 for speaker:Róisín Shortall

Written Answers — Department of Health: Health Services Staff Issues (18 Sep 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Applications (18 Sep 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: General Practitioner Services (18 Sep 2012)

Róisín Shortall: I propose to take Questions Nos. 1511, 1718, 1796, 1812 and 1823 together. The Programme for Government commits to reforming the current public health system by introducing Universal Health Insurance with equal access to care for all. As part of this, the Government is committed to introducing, on a phased basis, GP care without fees within its first term of office. Primary legislation is...

Written Answers — Department of Health: Long-Term Illness Scheme Applications (18 Sep 2012)

Róisín Shortall: There are no plans to extend the list of conditions covered by the Long Term Illness Scheme. Under the Drug Payment Scheme, no individual or family pays more than €132 per calendar month towards the cost of approved prescribed medicines. The scheme significantly reduces the cost burden for families and individuals incurring ongoing expenditure on medicines. In addition, people who...

Written Answers — Department of Health: Tax Reliefs Application (18 Sep 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medicinal Products Supply (18 Sep 2012)

Róisín Shortall: Roaccutane (active substance, isotretinoin) is authorised for treating severe forms of acne which have been resistant to other standard therapies. It should only be prescribed by or under the supervision of doctors with expertise in using the product and with a full understanding of the risks of therapy and the monitoring requirements. Under European and Irish legislation, all medicinal...

Written Answers — Department of Health: Universal Health Insurance Provision (18 Sep 2012)

Róisín Shortall: I propose to take Questions Nos. 1547 and 1548 together. The Programme for Government commits to reforming the current public health system by introducing Universal Health Insurance with equal access to care for all. As part of this, the Government is committed to introducing, on a phased basis, GP care without fees within its first term of office. Primary legislation is required to give...

Written Answers — Department of Health: Medicinal Products Supply (18 Sep 2012)

Róisín Shortall: Gilenya, which is used for the treament of Multiple Sclerosis, has been reimbursed on the High Tech Scheme since 1 July 2012. There is no restriction on the reimbursement of High Tech prescriptions for Gilenya which are written by Neurologists.

Written Answers — Department of Health: General Practitioner Services (18 Sep 2012)

Róisín Shortall: The Programme for Government provides for significant strengthening of primary care services to deliver Universal GP Care with the removal of cost as a barrier to access for patients. Universal GP Care will be achieved on a phased basis. Primary legislation is required to give effect to this commitment. Legislation to allow the Minister for Health to make regulations to extend access to GP...

Written Answers — Department of Health: Primary Care Centres Provision (18 Sep 2012)

Róisín Shortall: The information sought by the Deputy is collated by the HSE on an Integrated Service Area (ISA) basis and is set out in the attached tables. The HSE had identified a need for 518 Primary Care Teams (PCTs) by the end of 2012. This number has now been reduced to 485 PCTs, following realignment of team boundaries in some HSE areas. Number of Primary Care Teams Start of February 2011 End...

Written Answers — Department of Health: Medical Card Applications (18 Sep 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Water Fluoridation (18 Sep 2012)

Róisín Shortall: I propose to take Questions Nos. 1632, 1635 and 1838 together. The Irish Expert Body on Fluorides and Health, which was established in 2004, monitors new and emerging issues on fluoride and its effects on health and related matters. The Expert Body confirms that, based on the review of all previous and current international and national scientific data, the balance of evidence worldwide...

Written Answers — Department of Health: Medical Card Applications (18 Sep 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Drug Treatment Programmes Availability (18 Sep 2012)

Róisín Shortall: I propose to take Questions Nos. 1636, 1645, 1648 and 1834 together. In line with the Programme for Government and Action 34 of the National Drugs Strategy 2009-2016, it is Government policy to expand the availability of needle exchange services. Such services greatly reduce the risk of the use of contaminated injecting equipment through providing sterilised needles, syringes and...

Written Answers — Department of Health: HSE Staff Responsibilities (18 Sep 2012)

Róisín Shortall: The programme is continually evolving to encourage increased participation by healthcare professionals and patients. There are a range of methods in place to facilitate reporting, including paper based and downloadable post-paid report forms as well as online/telephone reporting. Detailed information and guidance on adverse reaction reporting, together with access to report forms, can be...

Written Answers — Department of Health: Medicinal Products Licensing (18 Sep 2012)

Róisín Shortall: Aliskiren (trade name Rasilez) is used to treat hypertension (high blood pressure) in adults. Rasilez is licensed in all EU Member States and is only available on prescription. A multinational study carried out in 2011 (ALTITUDE) to investigate aliskiren in a specific population of patients with type 2 diabetes and renal impairment found that aliskiren, when taken in combination with other...

Written Answers — Department of Health: Medical Card Applications (18 Sep 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Applications (18 Sep 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Applications (18 Sep 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Health Services Provision (18 Sep 2012)

Róisín Shortall: Some vitamin B12 injections are covered by the General Medical Services (GMS) scheme. If the Deputy can furnish me with the details of the injection in question, I will have the matter investigated.